First quarter of 2022: ASA continues to grow

08 April 2022 - Corporate -

The figures leave no room for doubt: for ASA, the first quarter of 2022, compared to the same period of 2021, continues to show growth, both in terms of turnover and in terms of the devices produced.

This is the result of a well thought-out commercial strategy aimed at consolidating existing businesses while developing high-potential markets.

“We have been achieving these objectives thanks to a solid policy of working alongside our long-term partners, to whom we offer continuous support in planning activities and new functional products and technologies to gain a leading role in the market. Instead, in countries we are approaching for the first time, we have been focusing on supporting daily information and training activities to promote the dissemination of our technologies and therapies”.

And during the first three months of the year, these therapies confirmed their growth and worldwide distribution.
The complex global socio-economic situation, together with the post-pandemic implications, has had a tangible impact on the company, but does not limit development projects.

“Pressure on prices, difficult-to-manage procurement schedules for components and packaging and significant increases in energy and transport costs are some of the critical issues we have to deal with on a daily basis. Unfortunately, we do not expect the situation to become stable any time soon, so we remain flexible and responsive to individual markets with very different commercial and training needs, but all equally relevant. Our distributors are aware of the situation and they are not quitting; they know that business is not only about the product: relationships and common visions are essential to win”,

concludes Federico Castellani - ASA Sales Manager.

You might also be interested in ...

See all articles

ASA 2021 consuntivo
News - 25/01/2022
Record-breaking results for ASA’s 2021, heading toward a 2022 that holds new challenges.
SA, case history di successo per il Master in Lean Management CUOA
News - 09/12/2021
Participants were able to visualise the steps that led ASA to implementing a One-Piece-Flow system during the assembly and testing phases of its laser therapy devices, thanks to the continuous...
M-VET into ADI Design Index 2021
News - 27/10/2021
Therapeutic and functional efficacy marry design, obtaining international acclaim not only from the world of veterinary medicine, but also from that of industrial design.
ASA laserterapia en la Universidad Autonoma de Chile
News - 12/05/2022
The Universidad Autónoma de Chile and the Universidad Andrés Bello hosted two in-depth sessions dedicated to MLS® Laser Therapy as part of two seminars entitled respectively “Physical agents: the...
Press - 03/05/2022
"We have treated almost 40 patients with laser therapy and all of them have experienced an improvement in their condition” - Jana Mahdalíková
MLS Laser Therapy for Hypoxia/Ischemia-Induced Rod Microglia
Blog - 20/04/2022
This study lays the foundations for many research perspectives in the field of photobiomodulation using near infrared laser radiation (NIR) and demonstrates the effectiveness of MLS® and its MiS...